Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CMP Pharma was founded by Henry Smith as Carolina Medical Products (CMP) Company in 1975 while he was a professor of drug manufacturing at the University of North Carolina at Chapel Hill’s School of Pharmacy. In 1982, CMP Pharma’s SPS® Suspension was the first FDA approved suspension form of Sodium Polystyrene Sulfonate for the treatment of hyperkalemia. Prior to this approval, Sodium Polystyrene Sulfonate was only avail...
CMP Pharma was founded by Henry Smith as Carolina Medical Products (CMP) Company in 1975 while he was a professor of drug manufacturing at the University of North Carolina at Chapel Hill’s School of Pharmacy. In 1982, CMP Pharma’s SPS® Suspension was the first FDA approved suspension form of Sodium Polystyrene Sulfonate for the treatment of hyperkalemia. Prior to this approval, Sodium Polystyrene Sulfonate was only available as a powder for suspension. Approvals followed for Isoniazid Oral Solution, USP, the only FDA approved liquid treatment for tuberculosis, as well as Hydrocortisone 1% in Absorbase®, Triamcinolone Acetonide 0.05% in Absorbase®, and Amantadine Hydrochloride Oral Solution. Other products include: Oracit® - a treatment for metabolic conditions Dermacloud Ointment – an OTC skin protectant Absorbase® - a non-prescription topical ointment for dry skin conditions Simethicone Drops – an OTC agent for relief of symptoms associated with gas in the digestive tract We’ve manufactured high-quality pharmaceutical products at our Farmville, North Carolina facility since 1986.

List your booth number for exhibitions, ask us